Lv51
862 积分 2025-05-16 加入
Selective type II TRK inhibitors overcome xDFG mutation mediated acquired resistance to the second-generation inhibitors selitrectinib and repotrectinib
8天前
已完结
Response to Repotrectinib After Development of NTRK Resistance Mutations on First- and Second-Generation TRK Inhibitors
8天前
已完结
Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers
10天前
已完结
Comparative efficacy and tolerability of pharmacological interventions for acute bipolar depression in adults: a systematic review and network meta-analysis
13天前
已完结
Allergic eye disease
15天前
已完结
Corticosteroid as Treatment in Infective Conjunctivitis: A Systematic Literature Review and Meta-Analysis
22天前
已关闭
Comprehensive Review of Chest Tube Management
1个月前
已完结
WHO global report on hypertension 2025
1个月前
已完结
Therapeutic cancer vaccines: advancements, challenges and prospects
1个月前
已完结
Conjunctivitis Preferred Practice Pattern
1个月前
已完结
皖公网安备34019202002308
